PRELUDE THERAPEUTICS INC
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -39.1% | -39.1% | -36.6% |
| FY2022 | -59.1% | -59.1% | -52.4% |
| FY2023 | -51.4% | -51.4% | -43.9% |
| FY2024 | -96.7% | -96.7% | -72.5% |
| FY2025 | -145.0% | -145.0% | -70.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -39.1% | -39.1% | -36.6% |
| FY2022 | -59.1% | -59.1% | -52.4% |
| FY2023 | -51.4% | -51.4% | -43.9% |
| FY2024 | -96.7% | -96.7% | -72.5% |
| FY2025 | -145.0% | -145.0% | -70.4% |